The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients
- PMID: 7985710
- DOI: 10.1016/0002-9343(94)90346-8
The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients
Abstract
Purpose: To determine whether bronchoalveolar lavage (BAL) remains a useful technique in assessing human immunodeficiency virus (HIV)-infected patients with pulmonary symptoms.
Patients and methods: All HIV-infected patients with pulmonary symptoms referred to a university hospital-based pulmonary service underwent bronchoscopy and BAL within 24 hours of referral. All samples were handled in a standardized fashion. The results of the lavage were compared with chest roentgenograms and clinical results.
Results: A total of 894 lavages were performed on HIV-infected patients over a 7-year period. The overall diagnostic yield was 60%, with 420 patients having Pneumocystis carinii. Infections other than P carinii were found in 185 cases, including 75 lavages with P carinii and another infection. The other infections included Mycobacterium tuberculosis (17 patients), Mycobacterium kansasii (15 patients), Histoplasma capsulatum (24 patients), Cryptococcus neoformans (17 patients), and bacterial infection (103 patients). For 364 lavages, no diagnosis was made. Chest roentgenograms were not useful in predicting what infection would be diagnosed. There was no difference in the yield of BAL over the 7-year period, despite the introduction of aerosol pentamidine prophylaxis and antiretroviral therapy.
Conclusion: Bronchoscopy with BAL continues to have a role in the evaluation of HIV-infected patients with pulmonary symptoms.
Similar articles
-
The role of two-segment bronchoalveolar lavage in the diagnosis of pulmonary infections.Chest. 1994 Aug;106(2):414-20. doi: 10.1378/chest.106.2.414. Chest. 1994. PMID: 7774312
-
Diagnosis of Pneumocystis carinii pneumonia by multiple lobe, site-directed bronchoalveolar lavage with immunofluorescent monoclonal antibody staining in human immunodeficiency virus-infected patients receiving aerosolized pentamidine chemoprophylaxis.Am Rev Respir Dis. 1992 Oct;146(4):838-43. doi: 10.1164/ajrccm/146.4.838. Am Rev Respir Dis. 1992. PMID: 1416407
-
Pneumocystis carinii pneumonia in Zimbabwe.Lancet. 1995 Nov 11;346(8985):1258-61. doi: 10.1016/s0140-6736(95)91862-0. Lancet. 1995. PMID: 7475717
-
Bronchoscopy in the human immunodeficiency virus-infected patient.Semin Respir Infect. 2003 Jun;18(2):80-6. Semin Respir Infect. 2003. PMID: 12840788 Review.
-
[Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:36-44. Enferm Infecc Microbiol Clin. 1998. PMID: 9859618 Review. Spanish.
Cited by
-
Evaluation of sensitivity of multiplex PCR for Detection of Mycobacterium tuberculosis and Pneumocystis jirovecii in clinical samples.J Clin Microbiol. 2010 Sep;48(9):3165-8. doi: 10.1128/JCM.00323-10. Epub 2010 Jul 14. J Clin Microbiol. 2010. PMID: 20631108 Free PMC article.
-
Diagnosis of pneumonia and monitoring of infection eradication.Drugs. 2000 Dec;60(6):1289-302. doi: 10.2165/00003495-200060060-00004. Drugs. 2000. PMID: 11152012 Review.
-
Management of Advanced HIV Disease.Infect Dis Clin North Am. 2019 Sep;33(3):743-767. doi: 10.1016/j.idc.2019.05.005. Epub 2019 Jun 27. Infect Dis Clin North Am. 2019. PMID: 31255383 Free PMC article. Review.
-
A rare case of CMV pneumonia in HIV-infection.Respir Med Case Rep. 2019 Oct 16;28:100945. doi: 10.1016/j.rmcr.2019.100945. eCollection 2019. Respir Med Case Rep. 2019. PMID: 31709138 Free PMC article.
-
Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.Clin Diagn Lab Immunol. 1999 Nov;6(6):970-6. doi: 10.1128/CDLI.6.6.970-976.1999. Clin Diagn Lab Immunol. 1999. PMID: 10548595 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical